Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $23.4 million.

  • Legend Biotech's Depreciation & Amortization (CF) fell 9.87% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 6.23%. This contributed to the annual value of $23.4 million for FY2024, which is 14.22% up from last year.
  • According to the latest figures from FY2024, Legend Biotech's Depreciation & Amortization (CF) is $23.4 million, which was up 14.22% from $20.5 million recorded in FY2023.
  • Legend Biotech's 5-year Depreciation & Amortization (CF) high stood at $23.4 million for FY2024, and its period low was $6.2 million during FY2020.
  • Its 3-year average for Depreciation & Amortization (CF) is $18.0 million, with a median of $20.5 million in 2023.
  • Data for Legend Biotech's Depreciation & Amortization (CF) shows a peak YoY skyrocketed of 101.03% (in 2023) over the last 5 years.
  • Over the past 5 years, Legend Biotech's Depreciation & Amortization (CF) (Yearly) stood at $6.2 million in 2020, then surged by 30.56% to $8.1 million in 2021, then rose by 24.99% to $10.2 million in 2022, then skyrocketed by 101.03% to $20.5 million in 2023, then increased by 14.22% to $23.4 million in 2024.